Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Solid Tumor × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

INDUSTRY 8 OTHER 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 3 Sarcoma, Kaposi 2 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Neoplasms 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibrosarcoma 1 Musculoskeletal Pain 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524024 2025-02-10

DC-CTL

Zhengzhou Revo-Gene Technology Co., LTD

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡